AIM ImmunoTech Inc. — Institutional Ownership
Which tracked institutions hold AIM, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
3
Funds holding
$31875
Total value held
Buying
3 added/new · 0 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | $14445 | 50864 | +50000 | +5787.04% |
| 2 | Goldman Sachs Group Inc | $9214 | 32444 | +32444 | NEW BUY |
| 3 | Ubs Group Ag | $8216 | 28931 | +28931 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.